Markets — Creditnavora

Wire

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO SEC Trading and Markets Director Addresses Data Challen vVardis Secures $175 Million Funding Round Before NYSE CNO Financial Group Sets $0.18 Quarterly Dividend, 59th Silverstein, MetroLoft and RXR Recapitalize 55 Broad St TVA Releases Fiscal Year 2026 Financial Results With Ex

markets

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Clinical-stage biotech Windward Bio priced its IPO at $17 and closed at $28.50 on its first trading day on Nasdaq.

SEC Trading and Markets Director Addresses Data Challenges

Speeches and Statements

vVardis Secures $175 Million Funding Round Before NYSE Debut

Economic News, Trends, Analysis

CNO Financial Group Sets $0.18 Quarterly Dividend, 59th Straight

All Financial Services & Investing

Silverstein, MetroLoft and RXR Recapitalize 55 Broad Street in Manhattan

All Financial Services & Investing

Markets

All Markets →

All Financial Services & Investing

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Speeches and Statements

SEC Trading and Markets Director Addresses Data Challenges

Economic News, Trends, Analysis

vVardis Secures $175 Million Funding Round Before NYSE Debut

All Financial Services & Investing

CNO Financial Group Sets $0.18 Quarterly Dividend, 59th Straight

Stay informed.

One concise briefing, weekly. No spam.

By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.